福建省乳腺癌靶向药物治疗现状及其治疗费用分析

目的：探讨福建省乳腺癌靶向药物治疗的现状，分析其治疗费用，为重特大疾病医保政策的制定提供参考依据。方法调阅福建省9地市医疗保险管理中心信息系统中录入的2012年1月~2014年12月21岁以上参保妇女数据库信息，提取乳腺癌患者资料；至广西、广州、珠海、厦门等地进行实地调研；组织有关部门专家学者以及癌症患者召开座谈会等。结果近几年，福建省乳腺癌发病率逐年增高，2012~2014年分别为51.70/10万、53.76/10万、54.26/10万；其中21~40岁妇女发病率升高明显，由2012年的9.13/10万上升至2014年的10.17/10万，呈现年轻化趋势；患者经济负担沉重，尤其联合应用靶向药物治疗费用高达22.7万/人。结论减轻乳腺癌等大病患者的治疗经济负担关键在于完善重特大疾病医疗保障体系，降低靶向药物治疗费用。

Treatment status and economic burden of breast cancer targeted drugs in Fujian Province

Objective To explore the current status of breast cancer targeted drug therapy in Fujian Province,and ana-lyze the economic burden of the treatment,so to provide a reference for the establishment of medical insurance policy of ma-jor catastrophic disease.Methods Obtaining the breast cancer patients' data during 2012 to 2014 from informational system of nine cities' medical insurance management center in Fujian Province;Operating investigation in Guangxi,Guangzhou, Zhuhai,Xiamen and other areas;Holding symposium with experts,scholars and cancer patients.Results In recent years, the incidence of breast cancer in Fujian Province increased year by year. The incidences in 2012,2013 and 2014 were 51. 70,53.76 and 54.26 per 100 000 people,respectively.The incidence for women who aged from 21 to 40 was particularly increased,from 9.13 per 100 000 in 2012 to 10.17 per 100 000 in 2014.The patients' economic burden was heavy,and the cost of targeted drug therapy reached to ￥ 227 000 per patient.Conclusion The key to reduce the economic burden of pa-tients with breast cancer and other serious illness was to improve the medical insurance system for major catastrophic dis-ease,and reduce the cost of targeted drugs.